Pharmaceuticals

Johnson & Johnson MedTech Introduces Velys Active Robotic-Assisted System for Planning and Instrumentation in Spinal Fusion Surgery

bexib
By bexib 0 Min Read

Velys recently received 510(k) clearance from the FDA for planning and instrumentation of spinal fusion procedures across the cervical, thoracic-lumbar and sacroiliac spine.

You Might Also Like

FDA Grants Fast Track Designation to Sumitomo Pharmaceuticals’ Novel Treatment for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Avian Flu Puts BARDA Back in the Spotlight

Sounds great – HCA CPD Certified by PharmaTimes Communications Awards

Gilead aims to ‘end the HIV epidemic’ through incremental progress

The Future of Biosimilars: Q&A with Matt Erich

Share This Article
Previous Article Technology Roundup: AI Adoption Increases, But AI Revenues Uncertain
Next Article Fed Chairman Daly’s Comments – Closely Monitor Labor Market Indicators – Investorempires.com
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Kai Qiu appointed CEO of Anext Bank
Fintech
Celebrate Chinese New Year in Covent Garden: dining, shopping and cultural experiences
Hospitality & Tourism
Cap One and Discover to complete acquisition in ‘early 2025’
Banking
52% of executives say they plan to use agents
Banking